Compare Stocks: IDXX, NVST, ISRG, and SYK

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
IDXX IDEXX Laboratories	$550.96 -2.8%	$561.04	$518.55 ▼ $769.98	$43.41B	1.54	614,175 shs	530,335 shs
ISRG Intuitive Surgical	$394.51 -1.7%	$391.45	$328.57 ▼ $603.88	$139.37B	1.46	4.06 million shs	1.99 million shs
NVST Envista	$28.05 -0.1%	$26.57	$18.77 ▼ $30.42	$4.51B	0.86	3.11 million shs	2.52 million shs
SYK Stryker	$338.80 -0.7%	$324.61	$281.00 ▼ $396.86	$130.11B	0.76	2.27 million shs	2.80 million shs

7 Stocks That Will Be Magnificent in 2026

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
IDXX IDEXX Laboratories	0.00%	-6.09%	-4.36%	+4.19%	-17.01%
ISRG Intuitive Surgical	0.00%	+4.14%	-1.94%	-6.32%	-18.21%
NVST Envista	0.00%	-0.62%	+3.93%	+20.70%	+30.02%
SYK Stryker	0.00%	-0.01%	+2.47%	+10.45%	-10.57%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
IDXX IDEXX Laboratories	$550.96 -2.8%	$561.04	$518.55 ▼ $769.98	$43.41B	1.54	614,175 shs	530,335 shs
ISRG Intuitive Surgical	$394.51 -1.7%	$391.45	$328.57 ▼ $603.88	$139.37B	1.46	4.06 million shs	1.99 million shs
NVST Envista	$28.05 -0.1%	$26.57	$18.77 ▼ $30.42	$4.51B	0.86	3.11 million shs	2.52 million shs
SYK Stryker	$338.80 -0.7%	$324.61	$281.00 ▼ $396.86	$130.11B	0.76	2.27 million shs	2.80 million shs

7 Stocks That Will Be Magnificent in 2026

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
IDXX IDEXX Laboratories	0.00%	-6.09%	-4.36%	+4.19%	-17.01%
ISRG Intuitive Surgical	0.00%	+4.14%	-1.94%	-6.32%	-18.21%
NVST Envista	0.00%	-0.62%	+3.93%	+20.70%	+30.02%
SYK Stryker	0.00%	-0.01%	+2.47%	+10.45%	-10.57%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
IDXX IDEXX Laboratories	2.60	Moderate Buy	$747.00	35.58% Upside
ISRG Intuitive Surgical	2.68	Moderate Buy	$508.68	28.94% Upside
NVST Envista	2.50	Moderate Buy	$29.31	4.50% Upside
SYK Stryker	2.79	Moderate Buy	$386.28	14.01% Upside

Current Analyst Ratings Breakdown

Latest IDXX, NVST, ISRG, and SYK Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
8/13/2026	SYK Stryker	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy
8/13/2026	SYK Stryker	Wolfe Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Outperform ➝ Peer Perform
8/12/2026	ISRG Intuitive Surgical	Sanford C. Bernstein Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Outperform
8/12/2026	ISRG Intuitive Surgical	KeyCorp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Overweight
8/12/2026	ISRG Intuitive Surgical	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Market Perform ➝ Outperform	$500.00
8/11/2026	IDXX IDEXX Laboratories	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Overweight	$800.00 ➝ $710.00
8/7/2026	NVST Envista	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Hold ➝ Strong-Buy
8/6/2026	NVST Envista	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Hold (C-) ➝ Hold (C)
8/6/2026	NVST Envista	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target		$23.00
8/6/2026	NVST Envista	Robert W. Baird Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target		$34.00
8/6/2026	NVST Envista	Mizuho Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target		$29.00

(Data available from 8/16/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
IDXX IDEXX Laboratories	$4.30B	10.09	$15.09 per share	36.52	$20.47 per share	26.92
ISRG Intuitive Surgical	$10.06B	13.85	$9.28 per share	42.52	$51.79 per share	7.62
NVST Envista	$2.72B	1.66	$2.17 per share	12.93	$19.15 per share	1.46
SYK Stryker	$25.12B	5.17	$16.87 per share	20.08	$62.54 per share	5.42

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
IDXX IDEXX Laboratories	$1.06B	$14.22	38.75	33.15	2.94	25.03%	71.96%	33.60%	11/2/2026 (Estimated)
ISRG Intuitive Surgical	$2.86B	$8.73	45.19	39.45	2.85	28.45%	16.91%	14.83%	10/20/2026 (Estimated)
NVST Envista	$47M	$0.58	48.35	17.10	1.34	3.33%	7.88%	4.33%	11/4/2026 (Estimated)
SYK Stryker	$3.25B	$9.65	35.11	20.21	2.16	14.43%	23.63%	11.39%	10/29/2026 (Estimated)

Latest IDXX, NVST, ISRG, and SYK Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/5/2026	Q2 2026	NVST Envista	$0.3353	$0.41	+$0.0747	$0.33	$716.11 million	$730.50 million
8/4/2026	Q2 2026	IDXX IDEXX Laboratories	$3.94	$4.27	+$0.33	$4.27	$1.20 billion	$1.22 billion
7/30/2026	Q2 2026	SYK Stryker	$3.49	$3.69	+$0.20	$3.30	$6.58 billion	$6.59 billion
7/16/2026	Q2 2026	ISRG Intuitive Surgical	$2.48	$2.80	+$0.32	$2.29	$2.83 billion	$2.89 billion

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
IDXX IDEXX Laboratories	N/A	N/A	N/A	N/A	N/A
ISRG Intuitive Surgical	N/A	N/A	N/A	N/A	N/A
NVST Envista	N/A	N/A	N/A	N/A	N/A
SYK Stryker	$3.52	1.04%	+7.58%	36.48%	32 Years

Latest IDXX, NVST, SYK, and ISRG Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
8/4/2026	SYK Stryker	quarterly	$0.88	1.04%	9/30/2026	9/30/2026	10/30/2026

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
IDXX IDEXX Laboratories	0.19	1.17	0.87
ISRG Intuitive Surgical	N/A	4.96	3.91
NVST Envista	0.47	2.43	2.07
SYK Stryker	0.59	2.16	1.33

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
IDXX IDEXX Laboratories	87.84%
ISRG Intuitive Surgical	83.64%
NVST Envista	N/A
SYK Stryker	77.09%

Insider Ownership

Company	Insider Ownership
IDXX IDEXX Laboratories	0.79%
ISRG Intuitive Surgical	0.60%
NVST Envista	0.99%
SYK Stryker	4.60%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
IDXX IDEXX Laboratories	11,000	78.78 million	78.16 million	Optionable
ISRG Intuitive Surgical	17,021	353.28 million	351.16 million	Optionable
NVST Envista	12,000	160.62 million	159.03 million	Optionable
SYK Stryker	56,000	383.57 million	365.93 million	Optionable

IDXX, NVST, ISRG, and SYK Headlines

Recent News About These Companies

HighTower Advisors LLC Acquires 37,269 Shares of Stryker Corporation $SYK

41 minutes ago | marketbeat.com

Promising Medical Stocks To Add to Your Watchlist - August 15th

August 15 at 2:00 PM | marketbeat.com

TD Asset Management Inc Cuts Stock Holdings in Stryker Corporation $SYK

August 15 at 7:11 AM | marketbeat.com

Suncoast Equity Management Cuts Stock Holdings in Stryker Corporation $SYK

August 15 at 7:03 AM | marketbeat.com

Osprey Private Wealth LLC Has $4.37 Million Holdings in Stryker Corporation $SYK

August 15 at 6:31 AM | marketbeat.com

Massachusetts Financial Services Co. MA Sells 20,617 Shares of Stryker Corporation $SYK

August 15 at 6:23 AM | marketbeat.com

Jennison Associates LLC Purchases New Shares in Stryker Corporation $SYK

August 15 at 6:23 AM | marketbeat.com

Stryker Corporation $SYK Stake Trimmed by Chilton Capital Management LLC

August 15 at 4:47 AM | marketbeat.com

DSM Capital Partners LLC Sells 3,383 Shares of Stryker Corporation $SYK

August 15 at 4:40 AM | marketbeat.com

Stryker Corporation $SYK Shares Sold by Fulton Breakefield Broenniman LLC

August 15 at 4:40 AM | marketbeat.com

Carrera Capital Advisors Lowers Position in Stryker Corporation $SYK

August 15 at 4:16 AM | marketbeat.com

SYK Stock Gains 3.8% Since March-End: What's Driving the Uptrend?

August 14 at 4:26 PM | zacks.com

Medical Stocks To Research - August 14th

August 14 at 1:03 PM | marketbeat.com

Can Stryker (SYK) Still Look Undervalued After Backlog Recovery?

August 14 at 8:09 AM | uk.finance.yahoo.com

Is SYK Worth Buying as Growth Improves but Execution Risks Persist?

August 13 at 2:50 PM | zacks.com

Can Stryker's Q2 Recovery and Guidance Support a Stronger Second Half?

August 13 at 2:50 PM | zacks.com

Stryker Up 13.6% in 3 Months as Recovery Gains Strength, What's Next?

August 13 at 2:50 PM | zacks.com

Bank of America Securities Sticks to Its Buy Rating for Stryker (SYK)

August 12, 2026 | theglobeandmail.com

PBH or SYK: Which Is the Better Value Stock Right Now?

August 12, 2026 | zacks.com

Stryker’s (SYK) Comeback Quarter Looks Great, But At What Cost?

August 11, 2026 | insidermonkey.com

Stryker Corporation $SYK Shares Sold by Handelsbanken Fonder AB

August 11, 2026 | marketbeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

IDXX, NVST, ISRG, and SYK Company Descriptions

IDEXX Laboratories NASDAQ:IDXX

$550.96 -15.97 (-2.82%)

Closing price 08/14/2026 04:00 PM Eastern

Extended Trading

$557.10 +6.13 (+1.11%)

As of 08/14/2026 07:48 PM Eastern

IDEXX Laboratories, Inc. develops, manufactures, and distributes products primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets in Africa, the Asia Pacific, Canada, Europe, Latin America, and internationally. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. It also provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and health monitoring, biological materials testing, and laboratory diagnostic instruments, and services for biomedical research community. In addition, the company offers diagnostic and health-monitoring products for livestock, poultry, and dairy; products that test water for various microbiological contaminants; point-of-care electrolytes and blood gas analyzers; in-clinic chemistry, blood and urine chemistry, hematology, immunoassay, urinalysis, and coagulation analyzers; and SNAP rapid assays test kits. Further, it provides Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, and Quanti-Tray products; and veterinary software and services for independent veterinary clinics and corporate groups. Additionally, the company offers human medical point-of-care products and laboratory diagnostics services. The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.

Intuitive Surgical NASDAQ:ISRG

$394.51 -6.76 (-1.68%)

Closing price 08/14/2026 04:00 PM Eastern

Extended Trading

$394.86 +0.35 (+0.09%)

As of 08/14/2026 07:59 PM Eastern

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. The company sells its products through direct sales organizations, such as capital and clinical sales teams. It has a collaboration agreement with FluoGuide A/S for head & neck cancer. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.

Envista NYSE:NVST

$28.04 -0.04 (-0.12%)

Closing price 08/14/2026 03:59 PM Eastern

Extended Trading

$28.03 -0.02 (-0.05%)

As of 08/14/2026 07:48 PM Eastern

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products. This segment also provides software packages, which include DTX Studio Implant; DTX Studio Lab; and DTX Studio Clinic, a software package offered with its imaging products. It offers its products under the Nobel Biocare, Alpha-Bio Tec, Implant Direct, Nobel Procera, Ormco, Spark, Orascoptic, Damon, Insignia, AOA brands. The Equipment & Consumables segment provides dental equipment and supplies, including digital imaging systems, software, and other visualization/magnification systems; endodontic systems and related products; restorative materials, rotary burs, impression materials, bonding agents, and cements; and infection prevention products. This segment offers its products under the Dexis, DTX Studio, Kerr, Metrex, Total Care, Pentron, Optibond, Harmonize, Sonicfill, Sybron Endo, and CaviWipes to dental offices, clinics, and hospitals. Envista Holdings Corporation was incorporated in 2018 and is headquartered in Brea, California.

Stryker NYSE:SYK

$338.80 -2.29 (-0.67%)

Closing price 08/14/2026 03:59 PM Eastern

Extended Trading

$339.14 +0.34 (+0.10%)

As of 08/14/2026 07:34 PM Eastern

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical and thoracolumbar systems that include fixation, minimally invasive and interbody systems used in spinal injury, complex spine and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment, and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, clinical communication and workflow solutions, and other medical device products that are used in various medical specialties, as well as patient and caregiver safety technologies. This segment also provides neurosurgical, neurovascular and craniomaxillofacial implant products, which include products used for minimally invasive endovascular procedures; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest IDXX, NVST, ISRG, and SYK Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest IDXX, NVST, ISRG, and SYK Earnings

Compare Dividends

Latest IDXX, NVST, SYK, and ISRG Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

IDXX, NVST, ISRG, and SYK Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

IDXX, NVST, ISRG, and SYK Company Descriptions

IDEXX Laboratories NASDAQ:IDXX

Intuitive Surgical NASDAQ:ISRG

Envista NYSE:NVST

Stryker NYSE:SYK

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools